OptimizeRxOPRX
About: OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Employees: 129
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
84% more capital invested
Capital invested by funds: $55.3M [Q4 2024] → $102M (+$46.4M) [Q1 2025]
12% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 17
1.74% more ownership
Funds ownership: 61.72% [Q4 2024] → 63.47% (+1.74%) [Q1 2025]
0% more funds holding
Funds holding: 87 [Q4 2024] → 87 (+0) [Q1 2025]
11% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 27
61% less call options, than puts
Call options by funds: $1.02M | Put options by funds: $2.62M
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Stifel David Grossman | 26%upside $16 | Buy Maintained | 9 Jun 2025 |
JMP Securities Constantine Davides | 10%upside $14 | Market Outperform Maintained | 13 May 2025 |
Financial journalist opinion
Based on 7 articles about OPRX published over the past 30 days
